Karolinska Development publishes prospectus relating to set off issue
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
STOCKHOLM - March 17, 2017. Karolinska Development AB's (publ) ("Karolinska Development" or the "Company") prospectus relating to a new issue of B-shares to the Company's convertible holders, with payment by set-off (the "Set-off Issue") was approved by and registered with the Swedish Financial Supervisory Authority on March 16, 2017.
The prospectus relating to Karolinska Development's Set-off Issue is now available at the Company's website (www.karolinskadevelopment.com) and the SEB Emissioner's website (www.sebgroup.se/prospectuses).
Karolinska Development has retained Advokatfirman Lindahl as legal adviser in connection with the Set-off Issue. SEB Emissioner acts as issuing agent in connection with the Set-off Issue.
For further information, please contact:
Jim Van heusden, CEO, Karolinska Development AB
Phone: +46 72 858 32 09, e-mail: email@example.com
Christian Tange, CFO, Karolinska Development AB
Phone: +46 73 712 14 30, e-mail: firstname.lastname@example.org
TO THE EDITORS
About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The Company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The Company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patients' lives while providing an attractive return on investment to shareholders.
Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.
Karolinska Development has established a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.
The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.
For more information, please visit www.karolinskadevelopment.com.
The information in this press release does not constitute an offer to acquire, subscribe for or otherwise trade in shares or other securities in Karolinska Development. Any invitation to the persons concerned to subscribe for shares in Karolinska Development will only be made through the prospectus referred to in this press release.
This press release may not be released, published or distributed, directly or indirectly, in or into the United States, Australia, Canada, Japan, New Zealand, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, registrations or other actions in addition to those required under Swedish laws and regulations. Nor may the information in this press release be forwarded, reproduced or disclosed in a manner that contravenes such restrictions or would entail such requirements. Failure to comply with this instruction may result in a violation of applicable securities laws.
No shares have been or will be registered under the U.S. Securities Act of 1933, as amended ("Securities Act"), or securities legislation in any state or other jurisdiction in the United States, and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an available exemption from the registration requirements of the Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States.
This press release may contain forward-looking statements which reflect Karolinska Development's current view on future events and financial and operational development. The words "intend", "estimate", "expect", "may", "plan", "anticipate" or similar expressions regarding indications or predictions of future developments or trends and which are not statements based on historical facts constitute forward-looking information. Although Karolinska Development believes that these statements are based on reasonable assumptions and expectations, Karolinska Development cannot give any assurances that such statements will materialize. Forward-looking statements are in its nature involved with both known and unknown risks and uncertainties, since it is depending on future events and circumstances. Forward-looking statements do not constitute any representations and warranties, and the outcome could differ materially from the information set out in the forward-looking statements.
This information is information that Karolinska Development AB (publ) (Nasdaq Stockholm: KDEV) is obligated to make public pursuant to the Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of Jim Van heusden, on March 17, 2017 at 08:00 (CET).
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via Globenewswire
Följ NASDAQ OMX
Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.
Senaste pressmeddelandena från NASDAQ OMX
NRT Technology Completes Acquisition of VisuaLimits, One of the Fastest Growing Gaming Supplier Companies in the US26.9.2017 16:00 | Pressmeddelande
Acquisition of VisuaLimits Strengthens NRT's Ability to Connect the Guest Experience(TM) Across the Entire Casino Resort LAS VEGAS, Sept. 26, 2017 (GLOBE NEWSWIRE) -- NRT Technologies, Inc., a wholly-owned subsidiary of NRT Technology Corp. (together, "NRT") today announced the successful completion of its acquisition of VisuaLimits, LLC ("VL"). On September 20 2017, NRT and Sightline Payments announced an agreement to merge, with the combined entity to be called NRT Sightline (the "Transaction"). Following close of the Transaction, which remains subject to gaming regulatory approvals, Sightline's CEO and Founder, Kirk Sanford, will assume the role of CEO of NRT Sightline. NRT's current Founder, President and CEO, John Dominelli, will become Chairman of NRT Sightline and will remain active in leading the overall company strategy with a keen focus on driving the technology roadmap. The acquisition of VL complements N
Datameer Unveils New Visual Paradigm for Interactive Exploration of Data at Scale26.9.2017 15:02 | Pressmeddelande
Datameer extends its big data platform to add interactive functionality that enables self-service exploration of entire big data sets in seconds SAN FRANCISCO and NEW YORK, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Datameer today unveiled an industry-first solution for instant, interactive visual exploration of entire datasets of any size. Being shown publicly for the first time at Strata Data Conference New York 2017, the new functionality will completely change the way analysts can work with big data directly within their data lake. Built on patent-pending dynamic indexing technology, Visual Explorer extends Datameer's core big data platform beyond integration, preparation and governed democratization of big data for analyses, to now add unconstrained interactive visual exploration of extremely large datasets. For the first time, data engineers and business analysts can use the same familiar spreadsheet-like interface to work with their data and with the click of a button, ins
IPsoft Launches Amelia Healthcare Practice to Transform the Healthcare Workforce and Patient Experience with Cognitive AI26.9.2017 14:00 | Pressmeddelande
NEW YORK, Sept. 26, 2017 (GLOBE NEWSWIRE) -- IPsoft, the leading digital labor company, is to launch a vertically focused portfolio of solutions for the healthcare industry based on its AI platform, Amelia. A series of Amelia Health Agent offerings are under development in a program of co-collaboration with healthcare providers, health systems, health insurers and life sciences organizations. The first releases will target high volume processes and interactions that will deliver tangible improvements for providers, insurers, carers and patients. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/04fe91f2-5d18-475f-b43e-7d1183aaba1b A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4758c05a-915d-4278-8f55-6ed323f7649f A video accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1be90122-0c
Percona Delivers MyRocks Storage Engine for MySQL26.9.2017 09:54 | Pressmeddelande
First Experimental Release of MyRocks with Percona Server for MySQL Enables Greater Performance at Lower Cost for High-Volume, Write-Intensive Workloads DUBLIN, Ireland, Sept. 26, 2017 (GLOBE NEWSWIRE) -- PERCONA LIVE OPEN SOURCE DATABASE CONFERENCE EUROPE - Percona, the company that delivers enterprise-class MySQL®, MongoDB® and other open source database solutions and services, today announced an experimental full release of Percona Server for MySQL 5.7 that includes the MyRocks storage engine. The powerful combination of Percona Server for MySQL and MyRocks will enable database administrators to achieve more throughput for high-volume, write-intensive workloads. Optimized for modern hardware, the product requires less storage space and reduces maintenance costs, providing increased ROI for on-premises and cloud-based applications. MyRocks, which integrates RocksDB as a MySQL storage engine, is optimized for modern hardware. When testing
Percona Monitoring and Management Adds New Capabilities for Improving MongoDB and MyRocks Performance26.9.2017 09:02 | Pressmeddelande
Free, Open Source Tool Monitors Performance and Provides Actionable Insights for MySQL and MongoDB Variants DUBLIN, Ireland, Sept. 26, 2017 (GLOBE NEWSWIRE) -- PERCONA LIVE OPEN SOURCE DATABASE CONFERENCE EUROPE - Percona, the company that delivers enterprise-class MySQL®, MongoDB® and other open source database solutions and services, today announced the release of Percona Monitoring and Management 1.3 (PMM), a significant update to the free and open-source platform for managing and monitoring MySQL®, MariaDB® and MongoDB® performance. This updated version adds new capabilities for improving the performance of MongoDB deployments and the MyRocks storage engine for MySQL. Percona Monitoring and Management provides point-in-time visibility and historical trending of database performance that enables DBAs and application developers to optimize the performance of their databases. Percona Monitoring and Management now includes: Query
Constellation Brands Plans Commercial Paper Program25.9.2017 22:30 | Pressmeddelande
VICTOR, N.Y., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE:STZ) (NYSE:STZ.B) announced today that it plans to launch a commercial paper program pursuant to which it will offer and sell unsecured, unsubordinated notes, on a private placement basis, in reliance on an exemption from registration under the Securities Act of 1933, as amended (the "Securities Act"). The notes will not be redeemable prior to maturity or subject to voluntary prepayment. The proceeds of the notes will be used for general corporate purposes. The notes to be offered have not been and will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy the company's notes under the commercial paper program. About Constellation Brands Const
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum